S48G (p.Ser48Gly) variant of ATRX (Chromatin remodeler ATRX)

S48G (p.Ser48Gly) in ATRX (Chromatin remodeler ATRX) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of Alpha thalassemia-X-linked intellectual disability syndrome. The available variant effect predictions contribute to a CATVariant prioritization score of 0.16 / 1. The record also includes population frequency data, published literature, and structural context.

S48G (p.Ser48Gly) variant details